Merck & Co. Inc. | Income Statement
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
44,086
42,109
38,773
39,496
39,981
42,446
Cost of Goods Sold (COGS) incl. D&A
15,981
15,214
14,528
13,363
12,579
13,065
Gross Income
28,105
26,895
24,245
26,133
27,402
29,381
SG&A Expense
18,795
17,704
16,808
15,642
19,401
19,608
EBIT
9,310
9,191
-
10,491
8,001
9,773
Unusual Expense
3,480
3,860
755
6,124
1,711
1,020
Non Operating Income/Expense
152
12,161
1,103
571
558
53
Interest Expense
801
732
672
693
754
772
Pretax Income
5,545
17,283
5,401
4,659
6,521
8,701
Income Tax
1,028
5,349
942
718
4,103
2,508
Consolidated Net Income
4,517
11,934
4,459
3,941
2,418
6,193
Net Income
4,404
11,920
4,442
3,920
2,394
6,220
Net Income After Extraordinaries
4,404
11,920
4,442
3,920
2,394
6,220
Net Income Available to Common
4,404
11,920
4,442
3,920
2,394
6,220
EPS (Basic)
1.47
4.07
1.56
1.41
0.87
2.32
Basic Shares Outstanding
2,963
2,894
2,816
2,766
2,730
2,664
EPS (Diluted)
1.47
4.07
1.56
1.41
0.87
2.32
Diluted Shares Outstanding
2,996
2,928
2,841
2,787
2,748
2,679
EBITDA
16,298
15,882
13,812
15,932
12,638
14,292
Non-Operating Interest Income
264
266
289
328
385
343
Minority Interest Expense
113
14
17
21
24
27
Equity in Affiliates (Pretax)
404
257
205
86
42
324
About Merck & Co.
View Profile
